On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...